Salvage high-dose chemotherapy in female patients with relapsed/refractory germ cell tumors: The EBMT experience.

被引：0
|
作者：
De Giorgi, Ugo
Richard, Sandrine
Badoglio, Manuela
Kanfer, Edward
Bourrhis, Jean Henri
Nicolas-Virelizier, Emmanuelle
Liouret, Bruno
Vettenranta, Kim
Martin, Sonja
Dreger, Peter
Schuler, Markus Kajo
Scarpi, Emanuela
Rosti, Giovanni
Selle, Frederic
Lanza, Francesco
Bregni, Marco
机构：
[1] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, Italy
[2] Hop Tenon, Paris, France
[3] EBMT Study Off, Paris, France
[4] Imperial Coll Healthcare NHS Trust, London, England
[5] Inst Gustave Roussy, Villejuif, France
[6] Ctr Leon Berard, Lyon, France
[7] CHU Strasbourg, Strasbourg, France
[8] Univ Helsinki, Helsinki, Finland
[9] Robert Bosch Krankenhaus, Stuttgart, Germany
[10] Heidelberg Univ Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[11] Univ Hosp Dresden, Dresden, Germany
[12] Univ Paris 06, Oncol, GHU Est Tenon, Paris, France
[13] Ist Ospitalieri Cremona, Cremona, Italy
[14] Osped Circolo, Busto Arsizio, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5558
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
    De Giorgi, U.
    Richard, S.
    Badoglio, M.
    Kanfer, E.
    Bourrhis, J. H.
    Nicolas-Virelizier, E.
    Vettenranta, K.
    Lioure, B.
    Martin, S.
    Dreger, P.
    Schuler, M. K.
    Thomson, K.
    Scarpi, E.
    Rosti, G.
    Selle, F.
    Mangili, G.
    Lanza, F.
    Bregni, M.
    [J]. ANNALS OF ONCOLOGY, 2017, 28 (08) : 1910 - 1916
  • [2] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
    Darren R Feldman
    Robert J Motzer
    Dean F Bajorin
    [J]. Nature Clinical Practice Urology, 2008, 5 : 78 - 79
  • [3] Is high-dose chemotherapy effective in patients with relapsed or refractory germ cell tumors?
    Feldman, Darren R.
    Motzer, Robert J.
    Bajorin, Dean F.
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (02): : 78 - 79
  • [4] High-dose chemotherapy (HDCT) as second salvage treatment in patients with multiple relapsed or refractory germ cell tumors
    Beyer, J.
    Hackenthal, M.
    Lorch, A.
    Neubauer, A.
    Dieing, A.
    Rick, O.
    Hartmann, J. T.
    Bokemeyer, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors
    Oing, Christoph
    Lorch, Anja
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (06) : 365 - 369
  • [6] Salvage high-dose chemotherapy for primary mediastinal nonseminomatous germ cell tumors: Single institute experience.
    Walker, John W. T.
    North, Scott A.
    Basappa, Naveen S.
    Venner, Peter M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [7] Salvage high-dose chemotherapy in patients with germ cell tumors - An Italian experience with 84 patients
    Rosti, G
    De Giorgi, U
    Salvioni, R
    Papiani, G
    Sebastiani, L
    Argnani, M
    Monti, G
    Ferrante, P
    Pizzocaro, G
    Marangolo, M
    [J]. CANCER, 2002, 95 (02) : 309 - 315
  • [8] Salvage high-dose chemotherapy for germ cell tumors
    Feldman, Darren R.
    Powles, Thomas
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (08) : 355 - 362
  • [9] Salvage high-dose chemotherapy in patients with refractory gestational trophoblastic neoplasia: the EBMT experience
    De Giorgi, U.
    Kanfer, E.
    Richard, S.
    Badoglio, M.
    Scarpi, E.
    Apperley, J.
    Selle, F.
    Bourrhis, J. H.
    Nicolas-Virelizier, E.
    Mangili, G.
    Renard, M.
    Bazarbachi, A.
    Schaefer-Eckart, K.
    Lioure, B.
    Bokemeyer, C.
    Lanza, F.
    Bregni, M.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S512 - S513
  • [10] High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors
    Lorch, A.
    Neubauer, A.
    Hackenthal, M.
    Dieing, A.
    Hartmann, J. T.
    Rick, O.
    Bokemeyer, C.
    Beyer, J.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (04) : 820 - 825
12345